OnCore Login

Return to Trial Database

GU09-145

Phase I/II Study of BNC105P in Combination With Everolimus or Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma Following Prior Tyrosine Kinase Inhibitors

Status

Study Completed

Cancer Type(s)

Kidney

Study Contact

Publications

Phase I results of a phase I/II trial of BNC105P with everolimus in metastatic renal cell carcinoma (mRCC) patients previously treated with VEGFR tyrosine kinase inhibitors
  • TE Hutson, LH Dang, RC Lauer, A Starodub, RJ Hauke, MD Galsky, KA Bylow, T Logan, CL Cowey, DC Bibby, G Kremmidiotis, EE Doolin, TC Lavranos, G Sonpavde, NM Hahn, C Sweeney, J Sarantopoulos
Phase I/II study of BNC105P in combination with everolimus or following everolimus for progressive metastatic renal cell carcinoma following prior tyrosine kinase inhibitors
  • TE Hutson, J Sarantopoulos, T Logan, G Sonpavde, MD Galsky, C Sweeney, DC Bibby, G Kremmidiotis, EE Doolin, NM Hahn
Phase I/II study of a BNC105P/everolimus regimen for progressive metastatic renal cell carcinoma (mRCC) following prior tyrosine kinase inhibitors
  • TE Hutson, LH Dang, RC Lauer, A Starodub, RJ Hauke, T Logan, KA Bylow, MD Galsky, DC Bibby, G Kremmidiotis, EE Doolin, TC Lavranos, AF Leske, NM Hahn, G Sonpavde, C Sweeney, J Sarantopoulos
A phase I/II trial of BNC105P with everolimus in metastatic renal cell carcinoma (mRCC)
  • SK Pal, AA Azad, S Bhatia, HA Drabkin, B Costello, J Sarantopoulos, R Kanesvaran, R Lauer, AN Starodub, RJ Hauke, CJ Sweeney, NM Hahn, G Sonpavde, S Richey, T Breen, G Kremmidiotis, AF Leske, E Doolin, DC Bibby, J Simpson, J Iglesias, TE Hutson

Trial Locations

All sites in which the trial GU09-145 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278